Determination of antigenic properties of vaccine derived poliovirus strains. 2010

Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
University of Thessaly, School of Health Sciences, Department of Biochemistry & Biotechnology, Microbiology-Virology Laboratory, Ploutonos 26 & Aiolou, 41221 Larissa, Greece.

In this study, the immunity level of the southern Greek population in the 1-10-year, 11-20-year, 21-30-year and 31-40-year age groups with regard to Sabin vaccine strains and a collection of 11 recombinant and three non-recombinant poliovirus vaccine strains was determined. The results showed the lowest neutralization titre in the 21-30-year-age group against poliovirus type 3. Moreover, the capsid coding region of OPV (oral poliovirus vaccine) derivatives was sequenced in order to identify mutations that might lead to antigenic changes. In Sabin-1 derivatives a tendency of accumulation of mutations was observed in or near antigenic sites while in Sabin-2 and Sabin-3 derivatives in sites known to be involved in restoring neurovirulence or eliminating their temperature-sensitive phenotype. It was concluded that the combination of mutations in the capsid coding region and not the number of specific mutations in antigenic sites determines the antigenic properties of OPV derivatives and their reactivity with human sera.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011051 Poliomyelitis An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5) Infantile Paralysis,Polio,Poliomyelitis, Nonpoliovirus,Poliomyelitis, Preparalytic,Encephalitis, Polio,Epidemic Acute Poliomyelitis,Polio Encephalitis,Poliomyelitis Infection,Poliomyelitis, Acute,Acute Poliomyelitis,Acute Poliomyelitis, Epidemic,Infection, Poliomyelitis,Infections, Poliomyelitis,Nonpoliovirus Poliomyelitis,Paralysis, Infantile,Poliomyelitides, Preparalytic,Poliomyelitis Infections,Poliomyelitis, Epidemic Acute,Polios,Preparalytic Poliomyelitis
D011055 Poliovirus Vaccine, Oral A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) Sabin Vaccine,Oral Poliovirus Vaccine,Vaccine, Oral Poliovirus,Vaccine, Sabin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
October 2007, Vaccine,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
June 2006, Biologicals : journal of the International Association of Biological Standardization,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
January 1978, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
January 2008, Voprosy virusologii,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
March 2005, Biologicals : journal of the International Association of Biological Standardization,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
January 2023, Le infezioni in medicina,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
January 1964, Rassegna medica sarda,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
November 2010, The New England journal of medicine,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
November 2010, The New England journal of medicine,
Vaia Pliaka, and Charis Achilleos, and Zaharoula Kyriakopoulou, and Dimitris Tsakogiannis, and Irene Georgia Anna Ruether, and Constantina Gartzonica, and Stamatina Levidiotou-Stefanou, and Panayotis Markoulatos
June 1963, Japanese journal of medical science & biology,
Copied contents to your clipboard!